Someone sold shares of Netflix, Alnylam Pharmaceuticals, JD.com, and Amazon.com on August 11th.
1 report, 1 independent
Updated Sep 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Someone sold shares of Netflix, Alnylam Pharmaceuticals, JD.com, and Amazon.com on August 11th.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Netflix
American subscription video on-demand over-the-top streaming service
-
Alnylam Pharmaceuticals
biopharmaceutical company
- AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.
- Alnylam Pharmaceuticals, SEC, Truist Financial, and Nasdaq were involved in insider trading disclosures, analyst ratings, and stock trading on June 6, 2026.
-
JD.com
Chinese e-commerce company
-
Amazon.com
e-commerce platform
Related events
- Bill Ackman's fund holds a significant stake in Netflix, which trades on the Nasdaq stock exchange.
- Netflix stock is listed on the Nasdaq exchange.
- Citi analysts are bullish on Netflix, believing the company can exceed its margin targets.
- Duolingo traded on the Nasdaq stock exchange on September 5, 2026, and was also noted as a successful recovery model.
- Netflix declined a higher bid from rival Paramount concerning the acquisition of Warner Bros. Discovery.